
Weekly methotrexate (50 mg/m2) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia
Keywords: شیمیدرمانی تک ماده; Methotrexate; Low-risk; Gestational trophoblastic neoplasia; Single-agent chemotherapy